Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05874726 · ClinicalTrials.gov registry record
Biological Sample Repository for Gastrointestinal Disorders
A clinical trial of Obesity and Diabetes Mellitus, Type 2, sponsored by Pichamol Jirapinyo, MD, MPH.
- Active
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT05874726: Active study of Obesity and Diabetes Mellitus, Type 2, sponsored by Pichamol Jirapinyo, MD, MPH.
NCT05874726 is a study of Obesity and Diabetes Mellitus, Type 2 that is active but no longer recruiting, run by Pichamol Jirapinyo, MD, MPH. The registered enrollment target is 500 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05874726, a study of Obesity and Diabetes Mellitus, Type 2, is active but no longer recruiting, sponsored by Pichamol Jirapinyo, MD, MPH.
- ACTIVE NOT RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study has the purpose of collecting biological samples from obese patients undergoing evaluation for weight loss by means of medical or endoscopic therapies; and of post bariatric surgery patients presenting with short- and long-term surgical complications. The aim is to enhance the overall understanding of the mechanisms leading to obesity, weight loss, failure to lose weight, and weight regain following treatment. Additional goals are to determine the efficacy of endoscopic and surgical procedures, to identify potential therapeutic targets and disease biomarkers that predict response to therapy.
Primary Outcome
Blood (10 ml) will be collected from the enrolled subjects, serum will be extracted and stored at -80 degrees for up to 10 years.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Blood Collection
- DIAGNOSTIC_TEST Urine Collection
- DIAGNOSTIC_TEST Tissue Sample Collection
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-07-19 |
| Est. Completion | 2029-04 |
What the registry record for NCT05874726 still lists
NCT05874726 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (39% lower).
The record links to 10 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Blood Collection is the first listed.
NCT05874726 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05874726 about?
NCT05874726 is a clinical study titled "Biological Sample Repository for Gastrointestinal Disorders". The goal of this observational study has the purpose of collecting biological samples from obese patients undergoing evaluation for weight loss by means of medical or endoscopic therapies; and of post bariatric surgery patients presenting with short- and long-term surgical complications. The aim is ...
What is the current status of trial NCT05874726?
This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2023-07-19. Estimated completion is 2029-04.
What conditions does trial NCT05874726 study?
This clinical trial studies the following conditions: Obesity, Diabetes Mellitus, Type 2, Diabetes Mellitus, Overweight, Overweight and Obesity.
What interventions are being tested in trial NCT05874726?
The interventions under investigation include: Blood Collection (DIAGNOSTIC_TEST), Urine Collection (DIAGNOSTIC_TEST), Tissue Sample Collection (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05874726?
This trial is sponsored by Pichamol Jirapinyo, MD, MPH, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05874726 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05874726's enrollment target sits among peer trials
500 135th of 1053 higher than 911 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI